Leuvectin Followed By Surgery in Treating Patients With Stage II or Stage III Prostate Cancer
Phase 2
Terminated
- Conditions
- Prostate Cancer
- Interventions
- Biological: Leuvectin
- First Posted Date
- 2003-10-29
- Last Posted Date
- 2014-07-29
- Lead Sponsor
- Vical
- Target Recruit Count
- 13
- Registration Number
- NCT00004050
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
🇺🇸Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States
Phase II Trial of Allovectin-7® for Head and Neck Cancer
Phase 3
Completed
- Conditions
- Head and Neck CancerSquamous Cell Carcinoma of the Oral Cavity or OropharynxHead and Neck NeoplasmsCarcinoma of the Head and Neck
- First Posted Date
- 2002-12-09
- Last Posted Date
- 2008-06-24
- Lead Sponsor
- Vical
- Registration Number
- NCT00050388
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States
🇺🇸University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
🇺🇸Louisiana State University, New Orleans, Louisiana, United States
Phase II Trial of Allovectin-7® for Metastatic Melanoma
Phase 2
Completed
- Conditions
- MelanomaMetastatic MelanomaMalignant MelanomaSkin Cancer
- First Posted Date
- 2002-08-28
- Last Posted Date
- 2011-07-07
- Lead Sponsor
- Vical
- Target Recruit Count
- 133
- Registration Number
- NCT00044356
- Locations
- 🇺🇸
Hematology Oncology Associates of Baltimore, Baltimore, Maryland, United States
🇺🇸Arizona Cancer Center, Tucson, Arizona, United States
🇺🇸Comprehensive Blood and Cancer Center, Bakersfield, California, United States
© Copyright 2025. All Rights Reserved by MedPath